Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05105958
What this trial is testing

Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Zurich 98
Testing effectiveness (Phase 2)Study completedNCT05542576
What this trial is testing

Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy

Who this might be right for
Parkinson DiseaseAmyotrophic Lateral Sclerosis
Amydis Inc. 13
Testing effectiveness (Phase 2)Study completedNCT05508074
What this trial is testing

Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)

Who this might be right for
Amyotrophic Lateral SclerosisALS
InFlectis BioScience 51
Testing effectiveness (Phase 2)Study completedNCT00005674
What this trial is testing

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Research Resources (NCRR)
Not applicableEnrolling By InvitationNCT06710626
What this trial is testing

Control of Assistive Devices Via Brain-Computer Interface Technology

Who this might be right for
Tetraplegia/TetraparesisAmyotrophic Lateral Sclerosis (ALS)Quadriplegia+2 more
Neuralink Corp 3
Testing effectiveness (Phase 2)Study completedNCT04322149
What this trial is testing

Multiple Doses of AT-1501-A201 in Adults With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Anelixis Therapeutics, LLC 54
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07743268
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
n-Lorem Foundation 6
Not applicableUnknownNCT03452618
What this trial is testing

Predictive Factors for the Diagnosis of Early Noninvasive Ventilation Equipment

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Toulouse 100
Early research (Phase 1)Study completedNCT00875446
What this trial is testing

First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
GlaxoSmithKline 76
Very early researchStudy completedNCT05903690
What this trial is testing

Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation

Who this might be right for
Gene Mutation
Beijing Tiantan Hospital 6
Large-scale testing (Phase 3)Looking for participantsNCT04220190
What this trial is testing

RAPA-501 Therapy for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC 41
Not applicableNot Yet RecruitingNCT07616050
What this trial is testing

Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients

Who this might be right for
Post-strokeParkinson DiseaseAmyotrophic Lateral Sclerosis+3 more
Marta Mondellini 70
Testing effectiveness (Phase 2)Study completedNCT00877604
What this trial is testing

Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 34
Not applicableStudy completedNCT02537132
What this trial is testing

"New Perspectives of Adaptation to NIV in ALS"

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Fondazione Don Carlo Gnocchi ETS 48
Large-scale testing (Phase 3)Study completedNCT05178810
What this trial is testing

Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Ferrer Internacional S.A. 313
Testing effectiveness (Phase 2)Study completedNCT02469896
What this trial is testing

A Trial of Tocilizumab in ALS Subjects

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig's Disease+1 more
Barrow Neurological Institute 22
Not applicableStudy completedNCT04719403
What this trial is testing

Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 79
Testing effectiveness (Phase 2)Study completedNCT01849770
What this trial is testing

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Who this might be right for
Sporadic Amyotrophic Lateral Sclerosis
University of Washington 75
Not applicableStudy completedNCT01639391
What this trial is testing

Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut Pasteur 19
Testing effectiveness (Phase 2)Study completedNCT02868580
What this trial is testing

Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuroscience Trials Australia 43
Next Page